Vol.70 No.2 March 2022
Current status of isolation of antimicrobial-resistant bacteria from companion animals in Japan
1)Laboratory of Veterinary Hygiene, School/Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Japan
2)Graduate School of Infectious Diseases, Hokkaido University
3)Rakuno Gakuen University, Emeritus professor
Abstract
Companion animals, such as dogs and cats are in close contact with humans, and have been closely deeply involved in our daily lives, ever since the first pet boom in Japan after World War II. As in human medicine, antimicrobial agents are used in veterinary medicine to treat various bacterial infections. In particular, cephalosporins and fluoroquinolones are widely used in companion animal medicine as well as in human clinical settings. Thus, isolation of extended-spectrum β-lactamase (ESBL) producing- and/or fluoroquinolone-resistant Enterobacterales and methicillin-resistant Staphylococcus spp. have also been reported from the companion animal medicine field. In the Action Plan on Antimicrobial Resistance (AMR) (2016-2020), AMR control measures are intensively tackled in a collaborative manner from the perspective of the One Health Approach, which includes not only human medicine, but also veterinary medicine and the environment. In this paper, we will introduce give an overview of the current status of isolation of antimicrobial-resistant bacteria derived from companion animals in Japan and discuss the need to include how companion animal medicine and companion animal derived antimicrobial-resistant bacteria control measures should be involved in the future Action Plan on AMR.
Key word
antimicrobial resistance, companion animal, Enterobacteriaceae, Staphylococcus, Enterococcus
Received
November 1, 2021
Accepted
November 25, 2021
Jpn. J. Chemother. 70 (2): 189-199, 2022
